|
|
Blood, 16 April 2009, Vol. 113, No. 16, pp. 3716-3725.
Prepublished online as a Blood First Edition Paper on November 18, 2008; DOI 10.1182/blood-2008-09-179754.
Previous Article | Next Article 
Submitted September 18, 2008
Accepted November 4, 2008
Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
Pierre Bruhns*, Bruno Iannascoli, Patrick England, David A Mancardi, Nadine Fernandez, Sylvie Jorieux, and Marc Daeron
Departement d'Immunologie, Unite d'Allergologie Moleculaire et Cellulaire, Institut Pasteur, Paris, France
INSERM, U760, Paris, France
CNRS, URA 2185, Paris, France
Laboratoire Francais du fractionnement et des Biotechnologies, Les Ulis, France
Laboratoire Francais du fractionnement et des Biotechnologies, Lille, France
* Corresponding author; email: bruhns{at}pasteur.fr.
Distinct genes encode six human receptors for IgG (hFc Rs), three of which have two or three polymorphic variants. The specificity and affinity of individual hFc Rs for the four human IgG subclasses is unknown. This information is critical for antibody-based immunotherapy which has been increasingly used in the clinics. We investigated the binding of polyclonal and monoclonal IgG1, IgG2, IgG3 and IgG4 to Fc RI, Fc RIIA, IIB and IIC, Fc RIIIA and IIIB and all known polymorphic variants. Wt and low-fucosylated IgG1 anti-CD20 and anti-RhD mAbs were also examined. We found: 1) that IgG1 and IgG3 bind to all hFc Rs; 2) that IgG2 bind not only to Fc RIIAH131, but also, with a lower affinity, to Fc RIIAR131 and Fc RIIIAV158; 3) that IgG4 bind to Fc RI, Fc RIIA, IIB and IIC and Fc RIIIAV158; 4) that the inhibitory receptor Fc RIIB has a lower affinity for IgG1, IgG2 and IgG3 than all other hFc Rs. We also identified parameters which determine the specificity and affinity of hFc Rs for IgG subclasses. These results document how hFc R specificity and affinity may account for the biological activities of antibodies. They therefore highlight the role of specific hFc Rs in the therapeutic and pathogenic effects of antibodies in disease.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Lazarou, J. A. G. Patino, R. M. Jennings, R. S. McIntosh, J. Shi, S. Howell, E. Cullen, T. Jones, J. R. Adame-Gallegos, J. A. Chappel, et al.
Inhibition of Erythrocyte Invasion and Plasmodium falciparum Merozoite Surface Protein 1 Processing by Human Immunoglobulin G1 (IgG1) and IgG3 Antibodies
Infect. Immun.,
December 1, 2009;
77(12):
5659 - 5667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hudrisier, B. Clemenceau, S. Balor, S. Daubeuf, E. Magdeleine, M. Daeron, P. Bruhns, and H. Vie
Ligand Binding but Undetected Functional Response of FcR after Their Capture by T Cells via Trogocytosis
J. Immunol.,
November 15, 2009;
183(10):
6102 - 6113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Perez, M. R. Costa, C. A. Todd, B. F. Haynes, and D. C. Montefiori
Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41
J. Virol.,
August 1, 2009;
83(15):
7397 - 7410.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|